share_log

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

这位GE Vernova分析师开始看好的分析报告; 这是周一的前五个评级开始。
Benzinga ·  10/21 09:01

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

华尔街顶级分析师改变了对这些顶级公司的展望。如需查看包括升级和降级在内的所有分析师评级变化的完整视图,请参阅我们的分析师评级页面。

  • Deutsche Bank analyst Nicole Deblase initiated coverage on GE Vernova Inc. (NYSE:GEV) with a Buy rating and announced a price target of $354. GE Vernova shares closed at $272.72 on Friday. See how other analysts view this stock.
  • Keybanc analyst Tim Rezvan initiated coverage on BKV Corporation (NYSE:BKV) with an Overweight rating and announced a price target of $23. Prologis shares closed at $18.45 on Friday. See how other analysts view this stock.
  • Jefferies analyst Andrew Tsai initiated coverage on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) with a Buy rating and announced a price target of $165. Sarepta Therapeutics shares closed at $127.08 on Friday. See how other analysts view this stock.
  • Benchmark analyst Josh Sullivan initiated coverage on ESCO Technologies Inc. (NYSE:ESE) with a Buy rating and announced a price target of $150. ESCO Technologies shares closed at $126.20 on Friday. See how other analysts view this stock.
  • Truist Securities analyst David Macdonald initiated coverage on Guardian Pharmacy Services, Inc. (NYSE:GRDN) with a Buy rating and announced a price target of $22. Guardian Pharmacy shares closed at $17.68 on Friday. See how other analysts view this stock.
  • 德意志银行分析师Nicole Deblase发起了对GE Vernova Inc.(纽交所:GEV)的研究报告,并给出了买入评级,目标股价为354美元。GE Vernova股票在周五收盘价为272.72美元。看看其他分析师对这只股票的看法。
  • Keybanc分析师tim Rezvan对BKV Corporation(纽交所:BKV)进行了覆盖,并给出了超配评级,目标股价为23美元。Prologis股票在周五收盘价为18.45美元。看看其他分析师对这只股票的看法。
  • Jefferies分析师Andrew Tsai对sarepta therapeutics, Inc.(纳斯达克:SRPT)进行了覆盖,并给出了买入评级,目标股价为165美元。Sarepta Therapeutics股票在周五收盘价为127.08美元。看看其他分析师对这只股票的看法。
  • Benchmark分析师Josh Sullivan对ESCO Technologies Inc.(纽交所:ESE)进行了覆盖,并给出了买入评级,目标股价为150美元。ESCO Technologies股票在周五收盘价为126.20美元。看看其他分析师对这只股票的看法。
  • Truist Securities分析师David Macdonald对Guardian Pharmacy Services, Inc.(纽交所:GRDN)进行了覆盖,并给出了买入评级,目标股价为22美元。Guardian Pharmacy股票在周五收盘价为17.68美元。看看其他分析师对这只股票的看法。

Considering buying GEV stock? Here's what analysts think:

考虑买入GEV股票吗?以下是分析师的看法:

  • Dow, S&P 500 Settle At Record High Levels, Record 6th Consecutive Week Of Gains: Fear Index Moves To 'Extreme Greed' Zone
  • 道琼指数、标准普尔500指数创纪录高点,连续第6周上涨:恐惧指数上升至'极度贪婪'区域
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发